140 related articles for article (PubMed ID: 35972746)
1. Alkali Citrate Content of Common Over-the-Counter and Medical Food Supplements.
Dai JC; Maalouf NM; Hill K; Antonelli JA; Pearle MS; Johnson BA
J Endourol; 2023 Jan; 37(1):112-118. PubMed ID: 35972746
[No Abstract] [Full Text] [Related]
2. Over-the-Counter Alkali Agents to Raise Urine pH and Citrate Excretion: A Prospective Crossover Study in Healthy Adults.
Canvasser NE; Rivera M; Bechis SK; Ingimarsson J; Knoedler J; Stern K; Stoughton CL; Wollin D; Borofsky M; Bhojani N; Tayeb ME; Kamphuis G; Leavitt D; Hsi RS; Scotland KB
Urology; 2022 Oct; 168():72-78. PubMed ID: 35843354
[TBL] [Abstract][Full Text] [Related]
3. Effect of a high-citrate beverage on urine chemistry in patients with calcium kidney stones.
Goldfarb DS; Modersitzki F; Asplin JR; Nazzal L
Urolithiasis; 2023 Jul; 51(1):96. PubMed ID: 37479949
[TBL] [Abstract][Full Text] [Related]
4. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
5. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
[TBL] [Abstract][Full Text] [Related]
6. Alkalinizing Agents: A Review of Prescription, Over-the-Counter, and Medical Food Supplements.
Stern KL; Canvasser N; Borofsky M; Gleason VM; Kamphuis G; El Tayeb MM; Hsi R; Scotland KB
J Endourol; 2020 Jan; 34(1):1-6. PubMed ID: 31333065
[No Abstract] [Full Text] [Related]
7. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
8. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
9. Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment.
Eisner BH; Asplin JR; Goldfarb DS; Ahmad A; Stoller ML
J Urol; 2010 Jun; 183(6):2419-23. PubMed ID: 20403610
[TBL] [Abstract][Full Text] [Related]
10. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
11. Successful management of uric acid nephrolithiasis with potassium citrate.
Pak CY; Sakhaee K; Fuller C
Kidney Int; 1986 Sep; 30(3):422-8. PubMed ID: 3784284
[TBL] [Abstract][Full Text] [Related]
12. Citrate and renal calculi: new insights and future directions.
Pak CY
Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
[TBL] [Abstract][Full Text] [Related]
13. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical versus Over-the-Counter Potassium Citrate: A Benchtop Comparison.
Wong DG; Elson L; Nottingham CU; Desai AC
Urol Pract; 2022 May; 9(3):205-211. PubMed ID: 37145541
[TBL] [Abstract][Full Text] [Related]
15. Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia.
Jhagroo RA; Wertheim ML; Penniston KL
Br J Clin Pharmacol; 2016 Jan; 81(1):131-6. PubMed ID: 26297809
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of potassium and magnesium, and citraturic response from potassium-magnesium citrate.
Koenig K; Padalino P; Alexandrides G; Pak CY
J Urol; 1991 Feb; 145(2):330-4. PubMed ID: 1988724
[TBL] [Abstract][Full Text] [Related]
17. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
Trinchieri A; Esposito N; Castelnuovo C
Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
[TBL] [Abstract][Full Text] [Related]
18. Complementary and Alternative Medicine Use in First-time and Recurrent Kidney Stone Formers.
Joshi A; Tallman JE; Calvert JK; Brewer T; Miller NL; Yang L; Asplin JR; Hsi RS
Urology; 2021 Oct; 156():58-64. PubMed ID: 34293376
[TBL] [Abstract][Full Text] [Related]
19. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
20. Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.
Tosukhowong P; Yachantha C; Sasivongsbhakdi T; Ratchanon S; Chaisawasdi S; Boonla C; Tungsanga K
Urol Res; 2008 Aug; 36(3-4):149-55. PubMed ID: 18560820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
